🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

RecruitingNAAges 18 Years - 85 YearsAllThe Second Hospital of Shandong University
NCT05270616 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection. Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy; Exclusion Criteria: 1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.
💊

What it tests

  • robotic surgery
  • uniport surgery
  • multiple- port surgery
📍

Where

1 site
The Second Hospital of Shandong University
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy